Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 222

Related Citations for PubMed (Select 20655381)

1.

Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.

Kono S, Yoshida K, Tomosugi N, Terada T, Hamaya Y, Kanaoka S, Miyajima H.

Biochim Biophys Acta. 2010 Nov;1802(11):968-75. doi: 10.1016/j.bbadis.2010.07.011. Epub 2010 Jul 22.

2.

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J.

Science. 2004 Dec 17;306(5704):2090-3. Epub 2004 Oct 28.

3.

Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.

De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J.

EMBO J. 2007 Jun 20;26(12):2823-31. Epub 2007 May 31.

4.

Hepcidin targets ferroportin for degradation in hepatocytes.

Ramey G, Deschemin JC, Durel B, Canonne-Hergaux F, Nicolas G, Vaulont S.

Haematologica. 2010 Mar;95(3):501-4. doi: 10.3324/haematol.2009.014399. Epub 2009 Sep 22.

5.

Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia.

di Patti MC, Maio N, Rizzo G, De Francesco G, Persichini T, Colasanti M, Polticelli F, Musci G.

J Biol Chem. 2009 Feb 13;284(7):4545-54. doi: 10.1074/jbc.M805688200. Epub 2008 Dec 18.

6.

Functional consequences of ferroportin 1 mutations.

Liu XB, Yang F, Haile DJ.

Blood Cells Mol Dis. 2005 Jul-Aug;35(1):33-46.

PMID:
15935710
7.

Anemic copper-deficient rats, but not mice, display low hepcidin expression and high ferroportin levels.

Jenkitkasemwong S, Broderius M, Nam H, Prohaska JR, Knutson MD.

J Nutr. 2010 Apr;140(4):723-30. doi: 10.3945/jn.109.117077. Epub 2010 Feb 17.

8.

Aceruloplasminemia.

Kono S.

Curr Drug Targets. 2012 Aug;13(9):1190-9. Review.

PMID:
22515740
9.

Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.

De Domenico I, Lo E, Ward DM, Kaplan J.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3800-5. doi: 10.1073/pnas.0900453106. Epub 2009 Feb 20. Erratum in: Proc Natl Acad Sci U S A. 2012 May 8;109(19):7583-6.

10.

Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.

Aigner E, Theurl I, Haufe H, Seifert M, Hohla F, Scharinger L, Stickel F, Mourlane F, Weiss G, Datz C.

Gastroenterology. 2008 Aug;135(2):680-8. doi: 10.1053/j.gastro.2008.04.007. Epub 2008 Apr 15.

PMID:
18505688
11.

Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin.

Delaby C, Pilard N, Gonçalves AS, Beaumont C, Canonne-Hergaux F.

Blood. 2005 Dec 1;106(12):3979-84. Epub 2005 Aug 4.

12.

Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.

Finkenstedt A, Wolf E, Höfner E, Gasser BI, Bösch S, Bakry R, Creus M, Kremser C, Schocke M, Theurl M, Moser P, Schranz M, Bonn G, Poewe W, Vogel W, Janecke AR, Zoller H.

J Hepatol. 2010 Dec;53(6):1101-7. doi: 10.1016/j.jhep.2010.04.039. Epub 2010 Aug 4.

13.

Hepcidin and ferroportin: the new players in iron metabolism.

De Domenico I, Ward DM, Kaplan J.

Semin Liver Dis. 2011 Aug;31(3):272-9. doi: 10.1055/s-0031-1286058. Epub 2011 Sep 7. Review.

14.

Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.

Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D, Ganz T, Halsall DJ, Cox TM, Vogel W.

Hepatology. 2005 Aug;42(2):466-72.

PMID:
15986403
15.

Is ferroportin-hepcidin signaling altered in restless legs syndrome?

Clardy SL, Wang X, Boyer PJ, Earley CJ, Allen RP, Connor JR.

J Neurol Sci. 2006 Sep 25;247(2):173-9. Epub 2006 Jun 8.

PMID:
16759669
16.

Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface.

Marques L, Auriac A, Willemetz A, Banha J, Silva B, Canonne-Hergaux F, Costa L.

Blood Cells Mol Dis. 2012 Feb 15;48(2):110-20. doi: 10.1016/j.bcmd.2011.11.005. Epub 2011 Dec 16.

PMID:
22178061
17.

The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.

Ge XH, Wang Q, Qian ZM, Zhu L, Du F, Yung WH, Yang L, Ke Y.

J Nutr Biochem. 2009 Nov;20(11):860-5. doi: 10.1016/j.jnutbio.2008.07.014. Epub 2008 Nov 22.

PMID:
19027283
18.

The molecular basis of iron overload disorders and iron-linked anemias.

Kaplan J, Ward DM, De Domenico I.

Int J Hematol. 2011 Jan;93(1):14-20. doi: 10.1007/s12185-010-0760-0. Epub 2011 Jan 7. Review.

PMID:
21210258
19.

Autocrine formation of hepcidin induces iron retention in human monocytes.

Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, Zoller H, Bellmann-Weiler R, Niederegger H, Talasz H, Weiss G.

Blood. 2008 Feb 15;111(4):2392-9. Epub 2007 Dec 11.

20.

Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.

Qiao B, Sugianto P, Fung E, Del-Castillo-Rueda A, Moran-Jimenez MJ, Ganz T, Nemeth E.

Cell Metab. 2012 Jun 6;15(6):918-24. doi: 10.1016/j.cmet.2012.03.018.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk